On the interactions of leflunomide and teriflunomide within receptor cavity — NMR studies and energy calculations

Verfasser / Beitragende:
[Jacek Kujawski, Marek Bernard, Elżbieta Jodłowska, Kornelia Czaja, Beata Drabińska]
Ort, Verlag, Jahr:
2015
Enthalten in:
Journal of Molecular Modeling, 21/5(2015-05-01), 1-12
Format:
Artikel (online)
ID: 605513317
LEADER caa a22 4500
001 605513317
003 CHVBK
005 20210128100659.0
007 cr unu---uuuuu
008 210128e20150501xx s 000 0 eng
024 7 0 |a 10.1007/s00894-015-2643-z  |2 doi 
035 |a (NATIONALLICENCE)springer-10.1007/s00894-015-2643-z 
245 0 0 |a On the interactions of leflunomide and teriflunomide within receptor cavity — NMR studies and energy calculations  |h [Elektronische Daten]  |c [Jacek Kujawski, Marek Bernard, Elżbieta Jodłowska, Kornelia Czaja, Beata Drabińska] 
520 3 |a Leflunomide is a disease-modifying antirheumatic drug with antiinflammatory and immunosuppressive activity used for the treatment of psoriatic and rheumatoid arthritis. It undergoes rapid metabolization to teriflunomide, a metabolite that is responsible for the biological activity of leflunomide. Continuing our investigations on the interactions of biologically important azahetarenes with the environment, we focused on leflunomide and its active metabolite, teriflunomide, considering the interactions teriflunomide-amino acid within the target protein (dihydroorotate dehydrogenase) using density functional theory, as well as ONIOM techniques. The results of theoretical studies have shown that the interactions of teriflunomide with tyrosine and arginine involve principally the amide fragment of teriflunomide. The presence of the internal hydrogen bond between (Z)-teriflunomide carbonyl oxygen and enolic hydroxyl decreases the interaction strength between teriflunomide and tyrosine or arginine. Even the E isomer of teriflunomide would usually provide a stronger interaction teriflunomide—amino acid than the Z isomer with the internal hydrogen bond. Graphical Abstract The interactions of leflunomide and teriflunomide within receptor cavityᅟ 
540 |a The Author(s), 2015 
690 7 |a DFT calculations  |2 nationallicence 
690 7 |a Hydrogen bond  |2 nationallicence 
690 7 |a Leflunomide  |2 nationallicence 
690 7 |a NMR calculations  |2 nationallicence 
690 7 |a Teriflunomide  |2 nationallicence 
700 1 |a Kujawski  |D Jacek  |u Department of Organic Chemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Grunwaldzka 6 street, 60-780, Poznań, Poland  |4 aut 
700 1 |a Bernard  |D Marek  |u Department of Organic Chemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Grunwaldzka 6 street, 60-780, Poznań, Poland  |4 aut 
700 1 |a Jodłowska  |D Elżbieta  |u Department of Organic Chemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Grunwaldzka 6 street, 60-780, Poznań, Poland  |4 aut 
700 1 |a Czaja  |D Kornelia  |u Department of Organic Chemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Grunwaldzka 6 street, 60-780, Poznań, Poland  |4 aut 
700 1 |a Drabińska  |D Beata  |u Department of Organic Chemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Grunwaldzka 6 street, 60-780, Poznań, Poland  |4 aut 
773 0 |t Journal of Molecular Modeling  |d Springer Berlin Heidelberg  |g 21/5(2015-05-01), 1-12  |x 1610-2940  |q 21:5<1  |1 2015  |2 21  |o 894 
856 4 0 |u https://doi.org/10.1007/s00894-015-2643-z  |q text/html  |z Onlinezugriff via DOI 
898 |a BK010053  |b XK010053  |c XK010000 
900 7 |a Metadata rights reserved  |b Springer special CC-BY-NC licence  |2 nationallicence 
908 |D 1  |a research-article  |2 jats 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-springer 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1007/s00894-015-2643-z  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Kujawski  |D Jacek  |u Department of Organic Chemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Grunwaldzka 6 street, 60-780, Poznań, Poland  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Bernard  |D Marek  |u Department of Organic Chemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Grunwaldzka 6 street, 60-780, Poznań, Poland  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Jodłowska  |D Elżbieta  |u Department of Organic Chemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Grunwaldzka 6 street, 60-780, Poznań, Poland  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Czaja  |D Kornelia  |u Department of Organic Chemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Grunwaldzka 6 street, 60-780, Poznań, Poland  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Drabińska  |D Beata  |u Department of Organic Chemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Grunwaldzka 6 street, 60-780, Poznań, Poland  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Journal of Molecular Modeling  |d Springer Berlin Heidelberg  |g 21/5(2015-05-01), 1-12  |x 1610-2940  |q 21:5<1  |1 2015  |2 21  |o 894